These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 22026752

  • 1. Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus.
    Harigaya Y, Ngo D, Lesse AJ, Huang V, Tsuji BT.
    BMC Infect Dis; 2011 Oct 25; 11():287. PubMed ID: 22026752
    [Abstract] [Full Text] [Related]

  • 2. Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.
    Sancak B, Yagci S, Gür D, Gülay Z, Ogunc D, Söyletir G, Yalcin AN, Dündar DO, Topçu AW, Aksit F, Usluer G, Ozakin C, Akalin H, Hayran M, Korten V.
    BMC Infect Dis; 2013 Dec 10; 13():583. PubMed ID: 24325260
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    Shen P, Zhou K, Wang Y, Song J, Liu Y, Zhou Y, Xiao Y.
    J Antimicrob Chemother; 2019 Sep 01; 74(9):2537-2543. PubMed ID: 31203362
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and molecular characteristics of heterogeneous vancomycin intermediate Staphylococcus aureus in a tertiary care center of northern China.
    Cheng X, Ma L, Wang Y, Sun W, Su J.
    Diagn Microbiol Infect Dis; 2024 Mar 01; 108(3):116180. PubMed ID: 38183897
    [Abstract] [Full Text] [Related]

  • 5. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.
    J Antimicrob Chemother; 2011 Jul 01; 66(7):1594-9. PubMed ID: 21525024
    [Abstract] [Full Text] [Related]

  • 6. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS, Jones RN, Rossi KL, Rybak MJ.
    J Antimicrob Chemother; 2009 Nov 01; 64(5):1024-8. PubMed ID: 19744978
    [Abstract] [Full Text] [Related]

  • 7. Vancomycin MIC and agr dysfunction in invasive MRSA infections in southern Brazil.
    Rossato AM, Primon-Barros M, Dias CAG, d'Azevedo PA.
    Braz J Microbiol; 2020 Dec 01; 51(4):1819-1823. PubMed ID: 33074551
    [Abstract] [Full Text] [Related]

  • 8. Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States.
    Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV.
    J Clin Microbiol; 2011 Dec 01; 49(12):4203-7. PubMed ID: 21976769
    [Abstract] [Full Text] [Related]

  • 9. Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.
    Butterfield JM, Tsuji BT, Brown J, Ashley ED, Hardy D, Brown K, Forrest A, Lodise TP.
    Antimicrob Agents Chemother; 2011 Dec 01; 55(12):5433-7. PubMed ID: 21930887
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Leonard SN, Rossi KL, Newton KL, Rybak MJ.
    J Antimicrob Chemother; 2009 Mar 01; 63(3):489-92. PubMed ID: 19136530
    [Abstract] [Full Text] [Related]

  • 11. Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.
    Pitz AM, Yu F, Hermsen ED, Rupp ME, Fey PD, Olsen KM.
    J Clin Microbiol; 2011 Jan 01; 49(1):269-74. PubMed ID: 20962147
    [Abstract] [Full Text] [Related]

  • 12. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
    Mirza HC, Sancak B, Gür D.
    Microb Drug Resist; 2015 Oct 01; 21(5):537-44. PubMed ID: 25919019
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units.
    Hu HC, Kao KC, Chiu LC, Chang CH, Hung CY, Li LF, Liu TP, Lin LC, Chen NH, Huang CC, Yang CT, Lu JJ.
    BMC Infect Dis; 2015 Oct 23; 15():444. PubMed ID: 26497595
    [Abstract] [Full Text] [Related]

  • 14. Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.
    Hu J, Ma XX, Tian Y, Pang L, Cui LZ, Shang H.
    PLoS One; 2013 Oct 23; 8(9):e73300. PubMed ID: 24069184
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus.
    Ozmen Capin BB, Tekeli A, Karahan ZC.
    Microb Drug Resist; 2020 Mar 23; 26(3):238-244. PubMed ID: 31545160
    [Abstract] [Full Text] [Related]

  • 18. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus].
    Feng NN, Wang Q, Song YL, He LX, Zhou CM, Xie HM, Li HY.
    Zhonghua Nei Ke Za Zhi; 2013 Apr 23; 52(4):318-22. PubMed ID: 23925360
    [Abstract] [Full Text] [Related]

  • 19. Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study.
    Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Faragon C, Malik M, Mendes RE, Jones RN, McNutt LA, Lodise TP.
    BMC Infect Dis; 2017 Aug 02; 17(1):534. PubMed ID: 28764660
    [Abstract] [Full Text] [Related]

  • 20. Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods.
    Riederer K, Shemes S, Chase P, Musta A, Mar A, Khatib R.
    J Clin Microbiol; 2011 Jun 02; 49(6):2147-50. PubMed ID: 21490190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.